990x120 (2) december 10 2020

Event Overview

Cell and gene therapies are revolutionizing next-generation therapeutics. Many researchers are now leveraging the power of CRISPR precision genome engineering in their cell and gene therapies research, from fixing mutations associated with disease to modifying immune cells to attack cancer. In this webinar, brought to you by Synthego, cell and gene therapy experts will discuss the applications of CRISPR in studying genetic diseases and beyond.

Topics to be covered
  • Decoding and repairing genetic disease with CRISPR and iPSCs
  • The future of cell and gene therapy using CRISPR
Thursday, December 10, 2020
2:00 - 3:30 PM, Eastern Time


Robert Deans, PhD
Chief Scientific Officer

Bruce Conklin, MD
Senior Investigator, Gladstone Institutes
Deputy Director, Innovative Genomics Institute
Professor, Departments of Medicine, Pharmacology, and Ophthalmology
University of California, San Francisco


Register Now

CRISPR Technologies for the New Era of Cell and Gene Therapy

You must have Javascript and Cookies enabled to access this webcast.

Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this webinar. The Scientist and sponsor(s) may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these webinars free of charge for our readers.